Magnetic catheter could simplify dialysis access for kidney patients
NCT ID NCT03708562
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a new device called the everlinQ endoAVF System in 24 adults with kidney failure who need dialysis. The device uses magnets and radiofrequency energy to create a connection between an artery and a vein, providing a way to access the blood for dialysis. The goal was to see if this less invasive method could work safely and effectively, potentially offering more options for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- everlinQ endoAVF System (a device that uses magnets and radiofrequency energy to create a connection between an artery and a vein)
- What this could lead to
- If successful, this device could offer a less invasive way to create dialysis access, potentially reducing complications and recovery time for kidney failure patients.
- What could go wrong
- This was a small, early study with only 24 participants, so results may not apply to everyone. The device may not work as well in real-world settings, and there are risks like infection or blood clots.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sanatorio Italiano
Asunción, Paraguay
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new graft keep dialysis access working longer?
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a new drug combo shield young hearts from transplant complications?